« Previous
Next »
Titles
- Classification of products as drugs and devices & additional product classification issues: final guidance : guidance for industry and FDA staff1
- Consideration of uncertainty in making benefit-risk determinations in medical device premarket approvals, de novo classifications, and humanitarian device exemptions: guidance for industry and Food and Drug Administration staff1